Rempex Pharmaceuticals
Latest round
- Series B
Last raised
- Nov 2011
Total raised
- $76M
Investors
- 5
About Rempex Pharmaceuticals
Founded in 2011, Rempex Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery and development of new antibacterial drugs to meet the growing clinical need created by multi-drug resistant bacterial pathogens.
Who invested in Rempex Pharmaceuticals
5 investors across 2 rounds
See all investors in Rempex Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rempex Pharmaceuticals
Who invested in Rempex Pharmaceuticals?
Rempex Pharmaceuticals has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rempex Pharmaceuticals raised?
Rempex Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Rempex Pharmaceuticals last raise money?
Rempex Pharmaceuticals's most recent round on record is a Series B, in Nov 2011.
What does Rempex Pharmaceuticals do?
Founded in 2011, Rempex Pharmaceuticals, Inc.
Where is Rempex Pharmaceuticals headquartered?
Rempex Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like Rempex Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Rempex Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Rempex Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.